These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7877421)

  • 1. Plasminogen activators in tissue extract of aural cholesteatoma.
    Nakamura M; Yamashiro Y; Nakahodo K; Sunagawa M; Huang GW; Kosugi T; Morimitsu T
    Laryngoscope; 1995 Mar; 105(3 Pt 1):305-10. PubMed ID: 7877421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of urokinase-type plasminogen activator (u-PA) in tissue extracts of antrochoanal polyp.
    Yamashiro Y; Nakamura M; Huang GW; Kosugi T
    Laryngoscope; 1992 Sep; 102(9):1049-52. PubMed ID: 1518351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator activity in human aqueous humor.
    Smalley DM; Fitzgerald JE; Taylor DM; Cone RE; O'Rourke J
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):48-53. PubMed ID: 8300363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR; Wagner EF; Collen D
    Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G; Bjornsson TD; Vlodavsky I
    J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
    De Petro G; Copeta A; Barlati S
    Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay.
    Kuo BS; Bjornsson TD
    Anal Biochem; 1993 Feb; 209(1):70-8. PubMed ID: 8465964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
    Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator in human megakaryocytes and platelets: immunocytochemical localization, immunoblotting and zymographic analysis.
    Jeanneau C; Sultan Y
    Thromb Haemost; 1988 Jun; 59(3):529-34. PubMed ID: 3142087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
    Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
    Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
    Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.
    Kirchheimer JC; Pflüger H; Ritschl P; Hienert G; Binder BR
    Invasion Metastasis; 1985; 5(6):344-55. PubMed ID: 4066206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
    Paloma MJ; Páramo JA; Rocha E
    Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of urokinase type-plasminogen activator found in chest fluid.
    Hayashi S; Yamada K
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):105-15. PubMed ID: 2109919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.